1218674

Stemline Therapeutics, Inc. — FEI 3012004287

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 31, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Sponsor, Contract Research Organization